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Abstract: The authors describe a diagnostically challenging case where a patient with previous squamous cell carcinoma of 
the tonsil developed a putative second primary squamous cell carcinoma in the lung (stage IV with lung and bone metastases). 
During palliative chemotherapy several episodes of severe infection occurred, eventually resulting in abscess formation in the 
hip and brain. The dilemma of distinguishing between metastasis and abscess and the therapeutic implications are discussed.
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Case Description
A 61-year-old Caucasian male with a history of T2 N1 M0 squamous cell carcinoma of the tonsil 
(Fig. 1A), curatively treated with surgery and adjuvant radiation therapy six years earlier and with a 
history of continued smoking and insulin-dependent diabetes mellitus was admitted to the hospital for 
chest pain. After excluding acute cardiac changes, diagnostic work-up revealed a large mass in the upper 
lobe of the left lung as well as multiple small nodules in both lungs and multiple osteolytic bone changes, 
with no evidence of locoregional recurrence in the head and neck region or of enlarged intrathoracic 
lymph nodes. Histology of the lung mass derived from bronchoscopy showed poorly differentiated 
squamous cell carcinoma (Fig. 1B). No clear differentiation between metastases from the previous head 
and neck cancer and a second primary tumor could be made. Given the long time interval between the 
diagnosis of cancer the ﬁ  rst time and the new ﬁ  ndings with the evidence of tumor cells in the bronchial 
tree, a therapeutic approach for metastatic non-small cell lung cancer was chosen.
Treatment consisted of three courses of carboplatin/vinorelbine and monthly zoledronic acid. In the 
following period of stable disease (no reduction in lesion size), the patient developed three consecutive 
episodes of pneumonia, each accompanied by elevated C-reactive protein (CRP) levels, and resulting 
in hospitalisation. During the third episode, almost one year after initial presentation of chest pain, 
detection of liver and adrenal gland metastases indicated disease progression. Therefore, second line 
treatment with pemetrexed was initiated. After eight treatments, restaging computed tomography showed 
stable disease, but was indicative of abscess formation around the right hip (Fig. 2). Distinctly elevated 
CRP levels were also present. Following drainage, systemic treatment with antibiotics was initiated, yet 
microbiological examination of the ﬂ  uid revealed sterile cultures. Six weeks later, the patient developed 
impaired vision, eventually leading to magnetic resonance imaging (MRI) of the brain. Different 
sequences were performed: T1-weighted with and without iv contrast, T2-weighted, ﬂ  uid attenuated 
inversion recovery (FLAIR) and diffusion-weighted. Two non-contiguous lesions were detected—a 
large cystic lesion in the right occipital lobe (Fig. 3) and a solid lesion in the subcutis (Fig. 4). The low 
apparent diffusion coefﬁ  cient (ADC) ratio, peripheral contrast enhancement and T2 hypointensity rim 
prompted the radiologist to state in his report that occipital lobe abscess was at least as likely as metas-
tasis. The other lesion in the subcutis corresponded to a non-ulcerated 2 cm large nodule by physical 
examination. During this period, CRP was normal. Given the patient’s history and diagnostic uncertainty, 
invasive characterisation of the occipital mass and excision of the subcutaneous lesion was attempted 
in order to differentiate between new metastases and non-malignant causes. The subcutaneous lesion 
was histologically conﬁ  rmed as poorly differentiated squamous cell carcinoma (Fig. 1C). During stereotactic 16
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biopsy, the other lesion was found to be a brain 
abscess and 15 ml of puriform ﬂ  uid were drained. 
Local and systemic antibiotic treatment was initi-
ated. Moreover, this time, the Gram’s stain showed 
inflammatory cells, but no bacterial or fungal 
source of infection could be determined. Further 
ﬂ  uid evaluations, e.g. for mycobacteria as potentially 
causative organisms were also negative. Two months 
later, imaging follow-up showed resolution of the 
occipital mass, consistent with the diagnosis of 
brain abscess.
Discussion
Patients with head and neck cancer, especially those 
who continue smoking, have an elevated risk for 
second primary tumors, which might arise in the same 
area, such as the esophagus, lungs or other organs.
1 
In a large analysis of more than 99,000 patients, 
lung cancer was the most common second primary.
2 
One of the reasons for the lower number of second 
Figure 1 A–C. Histology slides (x40) of poorly differentiated squa-
mous cell carcinoma in the tonsil, bronchial epithelium and skin.
Figure 2. Contrast-enhanced computed tomography scan of the right 
hip after iv contrast injection: abscess indicated by white arrow.
Figure 3. Axial T2 weighted and sagittal T1 weighted magnetic 
resonance image (MRI) after iv contrast administration: brain metas-
tasis vs. abscess?17
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primaries arising in the head and neck area might 
be that radiation treatment of the initial cancer also 
eradicates microscopic foci of potential second 
primaries.
3 Prognosis after diagnosis of a second 
primary is typically limited, e.g. 12 months median 
survival in the series by.
4 If both, the original lesion 
and the lung lesions are diagnosed as squamous 
cell cancers, the question arises whether the new 
lesion represents metastatic disease or a true second 
primary. In the present case, the occurrence of a 
second primary was somewhat more likely, although 
the histology slides really looked identical. As both 
lung and bone metastases were present, no serious 
therapeutic dilemma resulted (platinum-based 
chemotherapy and bisphosphonates without local 
measures would have been appropriate irrespec-
tive of diagnosis). Although not performed in the 
present case, human papilloma virus (HPV) typing 
and Comparative Genomic Hybridisation (CGH) 
analysis can be used in this setting for the differen-
tiation between second primary tumors versus 
metastasis.
5 HPV typing can be assessed on formalin 
ﬁ  xed parafﬁ  n embedded tissue.
The patient reported here suffered several infec-
tious complications during treatment. Thus, the 
detection of the brain lesion did not automatically 
result in the diagnosis of “brain metastasis”, which 
of course is a common ﬁ  nding in patients with 
metastatic lung cancer and which typically results in 
referral for palliative radiation therapy, although 
surgical resection might also be considered in a 
subgroup of patients. Both, abscesses and metastases 
typically form at the grey-white matter junction of 
the brain, but abscess is often related to adjacent 
localized cranial infection.
6 In both conditions, MRI 
more often detects multiple than a solitary lesion.
7,6 
As recently discussed, information on ADC ratios 
and rim characteristics might help differentiate 
between abscess and neoplasm
8 and also guided 
decision-making in the present case. Even in patients 
with known extracranial cancer metastases and a 
high risk for central nervous system involvement, 
newly detected brain lesions should not automatically 
be (mis)interpreted as dissemination from the malig-
nant tumor.
9,10 In immunocompromised patients 
and/or those with a recent history of infections, blood 
tests with or without examination of lesion ﬂ  uid 
might provide valuable information towards appro-
priate management.
11 Surgical aspiration and antibi-
otics should cure at least 90% of intracranial 
abscesses,
6 while the prognosis of patients with brain 
metastases from lung cancer is poor despite the 
management options available today.
12
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Figure 4. Different section of the MRI examination: cutaneous 
metastasis indicated by white arrow, note also the edema in the right 
hemisphere.